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cMGl is a primary esponse gene first identified in a rat intestinal epithelinl (RIE-1) c&-line [(1990)Oncogene 5, lOBI-10831. A namtJcrormttogene, 
including epidermal growth factor (EGF), angiotcnsin :;I (AII), serum and insulin rapidly induced _- 7 10 B-fold increases oTcMG1 mRNA in RIE-l 
cells, while transforming rowth factor-/I caused a Snlall rcduclion. Cyclic AMPelevating agents blocked the incrcasc of cMGI mRNA induced 
by EGF, The All-stimulated increase of cMG 1 mRNA wtls blocked by the depletion of protein kinnsc C, whcrcas the EGF-stimulated increase 
was not affcctcd, indicating that protein kinasc C~dcpenJcnt and -indcpendcnt signalling pathways timulate cMG1 expression. 
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I. INTRODUCTION 
Primary response genes are a class of genes whose 
expression is rapidly and transiently induced by the 
treatment of cells with agonists such as hormones, 
growth factors and mitogens (for review see [l]). Many 
of these genes have been identified by differential hy- 
bridization screening of cDNA libraries prepared using 
mRNA isolated from mitogen-stimulated ceils [1,2]. 
Several of the known primary response genes encode 
nuclear proteins which have been demonstrated to be 
either transcription factors or transcriptional modula- 
tors, including the proto-oncogenes c-fos and c-j~or, 
three members of the C2H2 zinc-finger family of pro- 
teins (egr-1, -2 and -3), and nut-77, a member of the 
steroid hormone receptor super-family [ 11. 
While several primary responsti genes have been iden- 
tified using mitogen-stimulated fibroblasts, fewer stud- 
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ies have addressed the question of early genetic re- 
sponses to growth Factors in epithelial cells. We have 
derived an epithelial cell-line (termed RIE-1) from the 
small intestine of a rat [3], and demonstrated that these 
cehs are mitogenically responsive to epidermal growth 
factor (EGF), insulin-like growth factors (IGFs) and 
the peptide hormone angiotensin I1 (All) [4-6]. Re- 
cently, we used differential hybridization screening of a 
cDNA library prepared from EGF-treated RIE-1 cel!s 
to identify an EGF-inducible gene, which we have 
termed cMG1 [7,8]. This is a member of a new family 
of primary response genes, which currently contains 
three members: TlSll [9,10] (also known as Nup475 
[I I] or TTP [12]), cMG I [7,8] (also known as TlSll b 
[lo]) and TISl Id [IO]. The sequences of the proteins in 
this Family show a marked conservation of a 67-amino 
acid region, the structure of which suggests the possible 
formation of two zinc-finger-like domains. Indeed, the 
TISl l/ Nup475 protein has been found to bind zinc and 
to be localized to the nucleus [I 11. These observations 
have led us and others to speculate that this family of 
proteins might constitute a novel group of mitogen- 
inducible transcription regulators [8,10,11]. 
The induction of TISI 1 expression has been studied 
in some detail using 3T3 fibroblasts [lO-131, PC12 pheo- 
chromocytoma cells [IO], and a murine B-cell hybrid- 
oma [14]. In contrast, there is very little information 
about the induced expression of cMGl/TISI 1 b. The 
purpose of this work, therefore, was to measure the 
induction of cMGl/TlSllb mRNA by various mito- 
gens in the RIE-1 epithelial cell line, and to define the 
signal transduction pathways regulating cMGl gene ex- 
pression. 
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2. EXPERIMENTAL 
2.1. hfafrrids 
Reagents for cell culture were obtained ttom Flow Laboratories. 
EGF was prepared from mouse submaxillary glands [IS]. Insulin, 
12.O-tctradecanoyl phorbol-13.acetate (TDA). 3.isobutyl-l-meth- 
ylxanthine (IBMX), prostuglandin El, forskolin and noradrcnaline 
were obtained from Sigma. [a-‘?P]dCTP, IGF-I and platelet-derived 
growth factor were obtained from Amersham International, trans- 
forming growth factor-p (TGF-~) was from R&D Systems, and All 
and bombcsin were from Bachcm. The cDNA probe for cMG 1 was 
a l2G2 bp EcoRI fragment spanning the coding sequence [8]. The 
probes for fis and glyceraldehyde phosphate dchydrogenase 
(GAPDH) were a 1 kb PsrI fra&mcnt of v-fos and a 950 bp HirldllI- 
Purl fragment of GAPDH provided by Dr. T. Rabbitts (MRC Labo- 
ratory of Molecular Biology, Cambridge) and Dr. L.C. Mahadevun 
(Department of Biochemistry, University of Oxrord) respectively, 
2.2. Cc/l t~~ainkwurtc~ a td tr~altnettfs 0 60 120 180 
Stock cultures of RIE-I and Swiss 3T3 cells were maintained and 
passaged as described previously [3.4,16]. Cells for experiments were 
grown on 9 cm dishes for 7-10 days, by which time they were confluenl 
and quiescent. Approximately IO’ cells (I dish of RIE-I cells, or 4 
dishes of 3T3 sells) were used per treatment. In most of the cxperi- 
mcnts described, the mitogens were added directly to the cells in the 
serum-deplered medium; however, similar results were obtained wltcn 
this medium had been rcplaccd with fresh serum-free medium immedi- 
ately before the addition of the mitogens. The cells were incubated 
with the mitogcns for the times indicated at 37”C, and were then lysed 
on the dish by the addition of06 ml (per dish) of denaturing solution 
(solution D of [I 71). Thecell lysstcs wcrc scraped intocentrifuge tubes, 
and the total RNA was isolated as described 1171. 
Time (min) 
Fig. I. Time-course of EGF-induced cMG I expression i RIE- I cells. 
Confluent, quic,cent cultures of RIE-I cells were incubated with EGF 
(100 ng/ml) at 37°C for the time indicated. RNA was prepared from 
the cells as described in the text, and aliquots (IO ,@ were analysed 
by Northern blotting. The blot w3s probed sequentially for cMG1 and 
GAPDH, and the autoradiographs were scanned using 3 Chromoscan 
densitometer. The results shown are the expression ofcMG1 relative 
to that in control cells, after correction for minor differences in the 
loading of RNA thai were revealed by the scans of the GAPDH 
autoradiograph. Similar results were obtained in 3 other experiments. 
3.3. htlpis of ANA 
Aliquots (IO ,ug) of the RNA samples were analysed by Northern 
blotting as described previously [IS]. DNA probes were labelkd witn 
“P to specific activities of approximately IO’ cpm/pg DNA using 
[a-‘zP]dCTP as described previously [191. Filters wcce prehybridized 
and hybridized as described [l9], washed at 65°C in several change5 
of 0.2 x SSC/O. 1% (w/v) SDS (I x SSC consists of IS0 mM NaCI, 15 
mM Na citrate), and exposed to X-ray film for between 6 and I8 h 
a1 -70°C with intensifier screens. When blots were analysed sequen- 
lially with cDNA probes for different primary response genes and 
GAPDH, each probe was removed by the immersion of the filter in 
water at 290°C; the removal ofthe probe was checked by an overnight 
exposure of the filter to X-ray film as described above, before the 
addition of the next labelled probe. The autoradiographs were scanned 
using a Chromoscun densitometer (Joyce-Loebl), and the values were 
corrected for any differences in loading that were revealed by scttns 
of the GAPDH autoradiographs. 
bers of other primary response gene families (e.g. c-fos, 
flu-1 and fm-2 [20]) a so show different ime-courses ofI 
induced expression, but the functional significance of 
these differences remains to be established. 
3.2. The stimhion of cMGI expression by wwious mi- 
togens 
We have investigated the ability of all the known 
mitogens for RIE- 1 cells to stimulate cMG I expression 
in these cells. As shown in Fig. 2a, EGF, AI1 and TPA 
all substantially stimulated cMGl expression (between 
3- to G-fold over the basal level in different experi- 
ments). In general, AI1 and TPA gave the greatest stim- 
ulation of cMG1 expression, while EGF was slightly 
less effective. In addition, insulin and IGF-1 induced 
smaller but consistent increases (about 2- to 3-fold) in 
the level of cMG1 mRNA (Fig, 2b). The addition of 
serum consistently gave a smaller stimulation than that 
obtained using the individual mitogens AII, TPA and 
EGF (Fig. 2). In contrast to the other factors tested, 
TGF/? caused a small but reproducible reduction of the 
level of cMG1 mRNA (Fig. 2a). This is an interesting 
result because, as in other epithelial cell lines, TGFP is 
a potent inhibitor of RIE-1 cell proliferation (R.D. 
Smith and K.D.B., unpublished results). 
3. RESULT? AND DISCUSSlON 
3.1. ?%ze-course of the induction ofcMGl 
The time-course of the induction of cMG1 mRNA in 
RIE-1 cells treated with EGF is shown in Fig. 1. cMG 1 
expression rose rapidly after the addition of EGF, 
reaching a maximum after 60 min and subsequently 
returning towards basal evels by 180 min. Experiments 
using TPA and AI1 indicated that maximal stimulation 
of cMG1 mRNA levels by these agents also occurred 
after approximately 60 min (data not shown). This is a 
somewhat slower and less transient response than that 
reported for the induction of the related TISl I mRNA 
in several cell types [ 10,13,14]. Similarly, different mem- 
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Varnum et al. [IO] found only ‘modest induction’ of 
cMGl/TISllb mRNA in 3T3 Abroblasts stimulated 
using EGF or fibroblast growth factor (FGF). These 
workers suggested that our original cloning of cMG1 
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Fig. 2. Stimulation of cMG I expression i RIE- I cells (a,b) and Swiss 
3T3 cells (c) by various mitogcns. Confluent, quiescent cell cultures 
were incubated at 37°C for 60 min, in the presence of the followinS 
mitogens: serum (SER; IO%, Y/V), EGF (100 ng/ml). TPA (30 nM). 
angiotensin 11 (AH; 100 nM). TGF,8 (I n&ml), IGF-1 (100 ndml), 
insulin (INS; I p&ml>, PDGF (10 ndml) or bombcsin @GM; 10 nM). 
Control cells (CON) received an equal volume addition of serum-free 
medium. RNA was prepared from the cells as described in the text. 
and aliquots (IO pug) wcrc analysed by Northern blotting. The blots 
were probed sequentially for cMGI and GAPDI-I. In (a) and (c). 
mitogens were added to the cells in the serum-depleted medium in 
which they had been grown. In (b), mitogens wcrc added tocells whose 
medium had been replaced with serum-free medium immediately be- 
fort the experiment ( o remove IGF-binding proteins which could 
interfere with the response to IGF-I). Similar results were obtained in 
at least two other experiments with each mitogen. 
5om an EGF-stimulated epi thelial cell line by differen- 
tial hybridization raised ‘the exciting possibility that 
cell-type-specilic differences’ occur in the response of 
this gene to the same ligand. In order to explore this 
possibility, we have studied cMG1 mRNA levels in 
Swiss 3T3 cells stimulated by various mitogens. As in 
RIE-1 cells, cMG1 mRNA levels were increased up to 
5-fold by serum, TPA or growth factors including EGF 
(Fig. 2~). Thus, the size of the induction of cMG1 
mRNA in Swiss 3T3 fibroblasts is apparently not signif- 
icantly different from that in the RI&l epithelial cells. 
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Fig 3. Dupendcnce ofthe stimulation ofcMG 1 expression on protein 
kinase C (PKC). Confiucnt, quic~nt cultures of RIE-I cells were 
pretrcaled for 77 h with TPA (300 nM) to down-modulate PKC, 
immunoreastivc PKC was decreased to 45% of control levels, as 
assessed by Western blotting. Control cells (open columns) and PKC- 
depleted cells (hatched columns) were incubated at 37’C for 60 min 
in the prssencc of EGF (100 @ml), TPA (30 nM) or angiotcnsin II
(All; 100 nM). RNA was prepared from thccells as dcscribecl in the 
text, and aliquots (10~(S) wcrc analyaed by Northern blotting. The blot 
was probed sequentially for cMG I and GAPDH. and the autorrdi- 
agraphs were scanned using a Chromoscan densitometer. The results 
shown are the expression of cMGl relative to that in the appropriate 
control cells, after correction for minor differences in the loading of 
RNA that were revcalcd by the scans ofthe GAPDH autoradiograph. 
Very similar rcsulu were obtained in a second experiment of this 
design, 
However, in both cell lines there is a significant basal 
expression of cMGlflIS1 lb mRNA (Fig. 2 and [lo]), 
and this reduces the proportional stimulation observed 
when compared to those primary response genes which 
show virtually undetectable basal expression, such as 
TISl 1 [lo] or c-fos [7,21,22] (see also Fig. 4). 
3.3. Signuliing pcrthwa)s insolved in the induction of 
cMG I expression 
The marked increase in cMG 1 mRNA levels in TPA- 
stimulated cells indicates that cMG1 gene expression 
can be induced via the activation of protein kinase C. 
We have therefore tested whether this control enzyme 
is involved in the signalling pathways by which other 
mitogens activate the cMG1 gene, by pretreating RI&l 
cells with TPA to down-regulate protein kinase C [23] 
before stimulating them with TPA, EGF or AI1 (Fig. 3). 
In the absence of pretreatment with TPA, each mitogen 
increased cMG1 mRNA levels. However, the responses 
to TPA and Al1 were effectively eliminated in protein 
kinase C-depleted cells (Fig. 31, indicating that there is 
an absolute requirement for protein kinase C in the 
stimulation of cMG1 expression by AII. Thus, although 
this concentration of AI1 transiently increases cyloplas- 
mic [Ca’*] from approximately 101) nM to 800 nM in 
these cells [6], this Ca” signal is apparently not suffi- 
cient for the AII-induced expression of cMG1. In con- 
trast to the response to TPA and AlI, the induction of 
3 
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Fig. 4. Expression of c-j& and cMG1 in response to cyclic AMP- 
elevating agents, Confluenl, quiescent cultures or RIE-I cells were 
incubated at 37% for 30 min or GO min, in the presence of EGF (30 
@ml), IBMX (100 PM), prostaglandin El (PGEI : 1 PM), forskolin 
(FOR; IO PM) or noradrcnaline (NOR; 10 PM) as indicated. RNA 
was prepared as described in the text, and tlliquots (IO pg) were 
analyscd by Northern blotting. The blots were probed scquenliully for 
cMG1, c-j& and GAPDH. and the results are shown for c-j& at 30 
min and cMG1 at 60 min. The potentiation by IBMXIFOR or 111~ 
EGF-stimulated C-JOY response was also detected in the 60smin sam- 
ples, and Ihe reduction by LBMXIFOR of the EGF-stimulated cMG I 
response was also detected in the 30-min samples (data no1 shown). 
cMG1 by EGF is not inhibited in TPA-pretreated cells 
(Fig. 3), indicating thai ;d protein kinase C-independent 
signalling pathway is utilised by the EGF receptor in 
inducing cMG1 expression. Similarly, the induction of 
TISl I by EGF or FGF in fibroblasts [13] or by intcr- 
leukin-6 in a B-cell hybridoma [143 can occur through 
protein kinase C-independent pathways. 
Among the agonists that have been found to stimu- 
late the expression of certain primary response genes arc 
those which activate the cyclic AMP pathway. For ex- 
ample, TISll expression in 3T3 fibroblaots is induced 
by treatment with forskolin [ll]. In RIE-1 cells, fors- 
kolin, prostaglandin El and noradrenaline, each used 
in the presence of the phosphodiesterase inhibit01 
IBMX, stimulate IO- to 50-fold accumulations of cyclic 
AMP (R.D. Smith and K.D.B., unpublished data). 
However, these cyclic AMP-elevating agents had no 
significant effect on the level of cMG1 mRNA in un- 
stimulated RIE-1 cells, and forskolin and IBMX caused 
a reduction in the stimulation of cMG1 expression by 
EGF (Fig. 4). This was not a non-specific inhibitory 
effect on gene expression, since the cyclic AMP-elevat- 
ing agents induced a small stimulation of c-jbs mRNA 
in the same experiment, and forskolin and IBMX poten- 
tiated the induction of c-fos mRNA by EGF (Fig. 4). 
Similarly, the elevation of cyclic AMP has previously 
been reported to potentiate the induction of c-fos 
mRNA by bombesin in Swiss 3T3 cells [24]. Thus, the 
elevation of cyclic AMP has .opposite effects on the 
expression of c-fos and cMG1 in RIE-1 cells. 
Taking all of these results together, it is clear that a 
similar range of agonists (and thus, presumably, sig- 
nalling pathways) regulate cMG1 mRNA expression i  
both RIE-1 and Swiss 3T3 cells. It is also apparent hat 
there are both similarities and differences between the 
regulation of cMG1 expression and that reported for 
the cMGl-related gene, TISI 1. It will therefore be of 
considerable interest o use reporter gene constructs to 
dissect and compare the promoter elements present in 
the cMGl and TISl 1 genes. 
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